BCAB Archived Articles
BioAtla, Inc.: Pioneering Conditionally Active Biologic Antibody Therapeutics for Solid Tumors
Published on March 11, 2025
BioAtla, Inc. (BCAB): Pioneering Conditionally Active Biologics for Cancer Treatment
Published on November 17, 2024
BioAtla, Inc. (NASDAQ:BCAB): Pioneering Conditionally Active Biologics for Solid Tumor Cancers
Published on September 24, 2024